Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Accusation against Eugene B. Whitney, M.D. Medical Board of California Case # 12 2002 133376, Decision December 15, 2004.
American Alliance of Cancer Pain Initiatives (2003). Statement on Intractable Pain Treatment Acts.
Agency for Healthcare Policy and Research (1992). Acute Pain Management. Rockville, MD.
Agency for Healthcare Policy and Research (1994). Management of Cancer Pain. Rockville, MD.
Bergman v. Chin., 2001 No. H205732-1 (Cal App Dept Super Ct 1999).
Cassell, E.J. (1982). The nature of suffering and the goals of medicine. New Eng J Med, 306: 639–645.
Cassell, E.J. (1991). The Nature of Suffering and the Goals of Medicine. New York: Oxford University Press.
Cleeland, C.S., Gonin, R., Hatfield. A.K., Pandya, K.J. (1994). Pain and its treatment in outpatients with metastatic cancer. New Eng J Med, 330: 592–596.
Dahl, J.L, Gordon, D.B. (2002). Joint commission pain standards: a progress report. American Pain Society Bulletin, 12: 1,11, 12.
Drug Enforcement Administration. Final Policy on Dispensing Controlled Substances for the Treatment of Pain. (2006) Vol. 71 Fed. Reg. available at wais.access.gps.gov (DOCID: fr06se06-137).
Estate of Henry James v. Hillhaven Corp., No. 89 CVS 64 (N.C. Super. Ct. Jan. 15, 1991).
Federation of State Medical Boards (1998). Model Guidelines for the Use of Controlled Substances for the Treatment of Pain.
Federation of State Medical Boards (2004). Model Policy for the Use of Controlled Substances for the Treatment of Pain Available at http://www.fsmb.org/pdf/2004_grpol_controlled_substances.pdf.
Fishman, S.M., Papazian, J.S., Gonzalez, B.S., Riches, P.S., Gilson, A. (2004). Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Pain Medicine, 5: 309–324.
Fohr, S.A. (1998). The double effect of pain medication: separating myth from reality. J Palliative Med, 1: 315–328.
Fox, E. (1997). Predominance of the curative model of medical care – a residual problem. JAMA, 278: 761–763.
General Accounting Office. (2002). Prescription Drugs – State Monitoring Programs Provide Useful Tool to Reduce Diversion.
Gilson, A.M, Joranson, D.E. (2001). Controlled substances and pain management: changes in knowledge and attitudes of state medical regulators. Journal Pain Symp Mgmt, 21: 227–237.
Hill, C.S., Jr., (1995), When will adequate pain treatment be the norm? JAMA, 274: 1870–73
Hill, C.S., Jr. (1996). Government regulatory influences on opioid prescribing and their impact on the treatment of pain of nonmalignant origin. Journal Pain Symp Mgmt, 11: 287–298.
House Resolution 3244 (2000). Title VI, Sec. 1603. Decade of Pain Control and Research.
In re Paul Bilder, M.D. Oregon Board of Medical Examiners, 1999.
Joint Commission for the Accreditation of Health care Institutions (2007). Comprehensive Accreditation Manual for Hospitals.
Joranson, D.E. (1995). Intractable pain treatment laws and regulations. American Pain Society Bulletin, 5: 1–3, 15–17.
Joranson, D.E. et al. (2002). Pain management and prescription monitoring. Journal Pain Symp Mgmt, 23: 231–238.
Morgan, J.P. (1985). American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse, 5: 163–173.
Morris, D.B. (1991). The Culture of Pain. Berkeley: University of California Press.
Musto, D.F. (1999). The American Disease: Origins of Narcotic Control. New York: Oxford University Press.
Pain & Policy Studies Group. University of Wisconsin Comprehensive Cancer Center (2005). State Continuing Medical Education Policies for Pain and Palliative Care.
Pain & Policy Studies Group. University of Wisconsin Comprehensive Cancer Center (2006). States with Prescription Monitoring Programs.
Pellegrino, E.D. (1998). Emerging ethical issues in palliative care. JAMA, 279: 1521–1522.
Public Broadcasting System (2001). Thirty Years of America’s Drug War – A Chronology. available at www.pbs.org/wgbh/pages/frontline/shows/drugs/cron.
Rich, B.A. (2000). A prescription for the pain: the emerging standard of care for pain management. William Mitchell L Rev, 26: 1–91.
Rosa Tomlinson, et al. v. Bayberry Care Center, et. al., 2003 Contra Costa County Superior Court, No. C-02-00120.
Taylor, C.L. (2004). Improving referral of patients to hospice through community physician outreach. Journal Pain Symp Mgmt, 28: 294–295.
United States v. Hurwitz, United States Court of Appeals for the Fourth Circuit, No. 05-4474 (2006).
Von Roenn, J.H, Cleeland, C.S., Gonin, R., Hatfield, A.K., Pandya, K.J. (1993). Physician attitudes and practice in cancer pain management: a survey from the eastern cooperative oncology group. Ann Int Med, 119: 121–126.
Weintraub, M., Satesh, S., Byrne, L., Maharaj, K., Guttmacher, L. (1991). Consequences of the 1989 New York state triplicate benzodiazepine prescription regulations. JAMA, 266: 2392–2397.
Weissman, D.E., Haddox, J.D. (1989). Opioid pseudoaddiction. Journal Pain Symp Mgmt, 36: 363–366.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Rich, B.A. (2009). Pain in Society: Ethical Issues and Public Policy Concerns. In: Biobehavioral Approaches to Pain. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78323-9_21
Download citation
DOI: https://doi.org/10.1007/978-0-387-78323-9_21
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78322-2
Online ISBN: 978-0-387-78323-9
eBook Packages: MedicineMedicine (R0)